共 65 条
[1]
Bohlin K(2012)RDS–CPAP or surfactant or both Acta Paediatr 101 24-28
[2]
Sweet DG(2019)European consensus guidelines on the management of respiratory distress syndrome–2019 update Neonatology 115 432-450
[3]
Carnielli V(2019)Neonatal intubation practice and outcomes: an international registry study Pediatrics 143 e20180902-e60
[4]
Greisen G(2020)An international survey of airway management education in 61 countries Br J Anaesth 125 e54-47.e5
[5]
Hallman M(2022)A randomized, controlled trial to investigate the efficacy of nebulized poractant alfa in premature babies with respiratory distress syndrome J Pediatr 246 40-55
[6]
Ozek E(2022)Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome Arch Dis Child Fetal Neonatal Ed 107 51-F319
[7]
Te Pas A(2020)Aerosolized calfactant for newborns with respiratory distress: a randomized trial Pediatrics 146 e20193967-83
[8]
Foglia EE(2020)Aerosolized calfactant in infants with RDS: surfactant replacement 2.0? Pediatrics 146 e2020021576-344
[9]
Ades A(2019)Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial Arch Dis Child Fetal Neonatal Ed 104 F313-207
[10]
Sawyer T(2021)Surfactant nebulization to prevent intubation in preterm infants: a systematic review and meta-analysis Pediatrics 148 e2021052504-undefined